1.
Geriatr Gerontol Int
; 16(10): 1167-1168, 2016 Oct.
Article
in English
| MEDLINE
| ID: mdl-27758059
Subject(s)
Bacteremia/microbiology , Depressive Disorder/etiology , Memory Disorders/etiology , Nocardia Infections/complications , Nocardia Infections/drug therapy , Aged , Arthritis, Rheumatoid/diagnosis , Arthritis, Rheumatoid/drug therapy , Bacteremia/drug therapy , Depressive Disorder/drug therapy , Depressive Disorder/physiopathology , Female , Follow-Up Studies , Humans , Infusions, Intravenous , Magnetic Resonance Imaging/methods , Memory Disorders/drug therapy , Memory Disorders/physiopathology , Nocardia/classification , Nocardia/isolation & purification , Nocardia Infections/diagnostic imaging , Prednisone/therapeutic use , Rare Diseases , Risk Assessment , Severity of Illness Index , Tomography, X-Ray Computed/methods , Treatment Outcome , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
2.
Mediterr J Hematol Infect Dis
; 3(1): e2011010, 2011.
Article
in English
| MEDLINE
| ID: mdl-21625314
ABSTRACT
Hepatitis B virus (HBV) infection constitutes a serious global health problem. Nowadays there are divergent data regarding the use of antiviral drugs to treat acute hepatitis B. We present here a case of a 62-year-old man affected by severe acute hepatitis B with progressive worsening of clinical and hepatic function. The patient was treated with entecavir without critical side effects. We observed rapid clinical and laboratory improvements and the disappearance of hepatitis B surface antigen (HBsAg). The treatment with entecavir was protracted until 17(th) week when the antibody anti-HBs appeared. Entecavir should be carefully considered for the treatment of severe acute hepatitis B cases.
3.
Eur J Gastroenterol Hepatol
; 19(8): 731-2, 2007 Aug.
Article
in English
| MEDLINE
| ID: mdl-17625449
